Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Lennar Corp. A

Start price
Target price
Perf. (%)
€62.00
15.12.20
-
15.12.21
20.16%
15.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher risks for its business
buy
Atmos Energy Corp.

Start price
Target price
Perf. (%)
€83.00
15.12.20
€88.00
15.12.21
4.82%
16.12.21

Could be worthwhile Investment >10% per year
buy
Lenovo Group Ltd

Start price
Target price
Perf. (%)
€0.71
15.12.20
€1.00
2.04%
17.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Volkswagen AG VZO

Start price
Target price
Perf. (%)
€147.28
15.12.20
€143.00
-0.26%
15.12.20

High valuation
Volkswagen AG VZO

Start price
Target price
Perf. (%)
€146.26
15.12.20
€143.00
0.23%
15.12.20

High valuation
Volkswagen AG VZO

Start price
Target price
Perf. (%)
€145.74
15.12.20
€143.00
0.36%
15.12.20

High valuation
buy
Infineon Technologies AG

Start price
Target price
Perf. (%)
€28.87
15.12.20
-
-0.07%
15.12.20

Known brand
Future proof or reliable business model
Risky Investment
Low dividend yield expected
buy
E.ON SE

Start price
Target price
Perf. (%)
€8.85
15.12.20
-
0.02%
15.12.20

Could be worthwhile Investment >10% per year
buy
AngloGold Ashanti Ltd. ADR

Start price
Target price
Perf. (%)
€17.95
15.12.20
-
15.12.21
6.41%
12.01.21

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Undervalued
buy
AngloGold Ashanti Ltd.

Start price
Target price
Perf. (%)
€17.94
15.12.20
-
15.12.21
7.86%
12.01.21

Revenue growth > 30% per year expected
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Veru Inc

Start price
Target price
Perf. (%)
€9.15
15.12.20
€6.00
15.12.21
-18.03%
29.01.21

Capable Management
Good culture
Probably not worthwhile Investment
Few uniques
buy
Phio Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€25.44
14.12.20
€36.00
24.53%
11.01.21

Could be worthwhile Investment >10% per year
buy
Jaguar Health Inc.

Start price
Target price
Perf. (%)
€61.20
14.12.20
€225.00
1282.35%
11.01.21

Could be worthwhile Investment >10% per year
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.30
14.12.20
-
14.12.21
169.86%
07.07.21

Probably not worthwhile Investment
buy
Inpixon

Start price
Target price
Perf. (%)
€64.50
14.12.20
€150.00
6.98%
11.01.21

Could be worthwhile Investment >10% per year
buy
Avinger Inc.

Start price
Target price
Perf. (%)
€4.88
14.12.20
€20.00
301.64%
11.01.21

Could be worthwhile Investment >10% per year
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€14.22
14.12.20
€15.00
2.11%
15.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
buy
TOP Ships Inc.

Start price
Target price
Perf. (%)
€20.80
14.12.20
€40.00
28.85%
11.01.21

Could be very worthwhile Investment >20% year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.72
14.12.20
€2.00
14.12.21
9.69%
11.01.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.00
14.12.20
€8.00
14.12.21
6.67%
11.01.21

Could be very worthwhile Investment >20% year
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.20
14.12.20
€11.00
14.12.21
15.85%
29.01.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€4.53
14.12.20
€5.00
14.12.21
-24.50%
29.01.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.90
14.12.20
€2.00
14.12.21
158.23%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
CBAK Energy Technology Inc

Start price
Target price
Perf. (%)
€4.06
14.12.20
€4.00
3.94%
16.12.20

Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth